These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29592868)

  • 21. Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components.
    Scardoni M; Vittoria E; Volante M; Rusev B; Bersani S; Mafficini A; Gottardi M; Giandomenico V; Malleo G; Butturini G; Cingarlini S; Fassan M; Scarpa A
    Neuroendocrinology; 2014; 100(4):310-6. PubMed ID: 25342539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal poorly differentiated neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas: insights into the diagnostic immunophenotype, assessment of methylation profile, and search for prognostic markers.
    La Rosa S; Marando A; Furlan D; Sahnane N; Capella C
    Am J Surg Pathol; 2012 Apr; 36(4):601-11. PubMed ID: 22314183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of neuroendocrine components in gastric carcinomas.
    Park JY; Ryu MH; Park YS; Park HJ; Ryoo BY; Kim MG; Yook JH; Kim BS; Kang YK
    Eur J Cancer; 2014 Nov; 50(16):2802-9. PubMed ID: 25201164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.
    Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS
    J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters.
    Crippa S; Partelli S; Bassi C; Berardi R; Capelli P; Scarpa A; Zamboni G; Falconi M
    Surgery; 2016 Mar; 159(3):862-71. PubMed ID: 26602841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.
    Yachida S; Vakiani E; White CM; Zhong Y; Saunders T; Morgan R; de Wilde RF; Maitra A; Hicks J; Demarzo AM; Shi C; Sharma R; Laheru D; Edil BH; Wolfgang CL; Schulick RD; Hruban RH; Tang LH; Klimstra DS; Iacobuzio-Donahue CA
    Am J Surg Pathol; 2012 Feb; 36(2):173-84. PubMed ID: 22251937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High neuroendocrine component is a factor for poor prognosis in gastrointestinal high-grade malignant mixed adenoneuroendocrine neoplasms.
    Chen MH; Kuo YJ; Yeh YC; Lin YC; Tzeng CH; Liu CY; Chang PM; Chen MH; Jeng YM; Chao Y
    J Chin Med Assoc; 2015 Aug; 78(8):454-9. PubMed ID: 26002564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic Categories.
    Milione M; Maisonneuve P; Spada F; Pellegrinelli A; Spaggiari P; Albarello L; Pisa E; Barberis M; Vanoli A; Buzzoni R; Pusceddu S; Concas L; Sessa F; Solcia E; Capella C; Fazio N; La Rosa S
    Neuroendocrinology; 2017; 104(1):85-93. PubMed ID: 26943788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precise microdissection of gastric mixed adeno-neuroendocrine carcinoma dissects its genomic landscape and evolutionary clonal origins.
    Qiu MZ; Chen Q; Zheng DY; Zhao Q; Wu QN; Zhou ZW; Yang LQ; Luo QY; Sun YT; Lai MY; Yuan SS; Wang FH; Luo HY; Wang F; Li YH; Zhang HZ; Xu RH
    Cell Rep; 2023 Jun; 42(6):112576. PubMed ID: 37285266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocrine cell carcinomas of the colon and rectum: a clinicopathological evaluation.
    Komatsubara T; Koinuma K; Miyakura Y; Horie H; Morimoto M; Ito H; Lefor AK; Sata N; Fukushima N
    Clin J Gastroenterol; 2016 Feb; 9(1):1-6. PubMed ID: 26699873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.
    Basturk O; Yang Z; Tang LH; Hruban RH; Adsay V; McCall CM; Krasinskas AM; Jang KT; Frankel WL; Balci S; Sigel C; Klimstra DS
    Am J Surg Pathol; 2015 May; 39(5):683-90. PubMed ID: 25723112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second-line treatment and prognostic factors in neuroendocrine carcinoma: the RBNEC study.
    Hadoux J; Walter T; Kanaan C; Hescot S; Hautefeuille V; Perrier M; Tauveron I; Laboureau S; Do Cao C; Petorin C; Blanchet O; Faron M; Leteurtre E; Rousselet MC; Joubert Zakeyh J; Marchal A; Chatelain D; Beaulaton C; Hervieu V; Lombard-Bohas C; Ducreux M; Scoazec JY; Baudin E; ;
    Endocr Relat Cancer; 2022 Oct; 29(10):569-580. PubMed ID: 35920609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Characterization of Neuroendocrine Carcinomas of the Endometrium: Representation in All 4 TCGA Groups.
    Howitt BE; Dong F; Vivero M; Shah V; Lindeman N; Schoolmeester JK; Baltay M; MacConaill L; Sholl LM; Nucci MR; McCluggage WG
    Am J Surg Pathol; 2020 Nov; 44(11):1541-1548. PubMed ID: 32773531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prognostic analysis and clinicopathological features of 20 patients with appendiceal neuroendocrine neoplasms].
    Mao W; Lyu Y; Pu N; Li J; Xin B; Chen W; Jin D; Lou W; Xu X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):564-568. PubMed ID: 29774940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct clinicopathologic features, genomic characteristics and survival of central and peripheral pulmonary large cell neuroendocrine carcinoma: From different origin cells?
    Zhou F; Hou L; Ding T; Song Q; Chen X; Su C; Li W; Gao G; Ren S; Wu F; Fan J; Wu C; Zhang J; Zhou C
    Lung Cancer; 2018 Feb; 116():30-37. PubMed ID: 29413048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary Biliary Mixed Adenoneuroendocrine Carcinoma (MANEC): A Short Review.
    Acosta AM; Wiley EL
    Arch Pathol Lab Med; 2016 Oct; 140(10):1157-62. PubMed ID: 27684986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative Outcomes in Patients With Small- and Large-Cell Neuroendocrine Carcinoma (NEC) and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm (MiNEN) of the Stomach.
    Choi NY; Kim BS; Oh ST; Yook JH; Kim BS
    Am Surg; 2021 Apr; 87(4):631-637. PubMed ID: 33142079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of genome-wide copy number aberrations in colonic mixed adenoneuroendocrine carcinoma and neuroendocrine carcinoma reveals recurrent amplification of PTGER4 and MYC genes.
    Sinha N; Gaston D; Manders D; Goudie M; Matsuoka M; Xie T; Huang WY
    Hum Pathol; 2018 Mar; 73():16-25. PubMed ID: 28899736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas.
    Lamarca A; Walter T; Pavel M; Borbath I; Freis P; Nuñez B; Childs A; McNamara MG; Hubner RA; Garcia-Carbonero R; Meyer T; Valle JW; Barriuso J
    J Natl Cancer Inst; 2017 Jan; 109(5):. PubMed ID: 28130474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.